The benefits of therapeutic hypothermia have been well-documented. One way of causing a therapeutic state of hypothermia in a patient is by the use of surface cooling techniques such as ice baths. Recently, intravascular techniques have gained a foothold due to their increased controllability and speed. However, both of these techniques are typically administered in a hospital or clinical setting due to their difficulty in field administration.
Nevertheless, physicians desire to initiate significant cooling in the field, e.g., enroute to the hospital or ER. Therapeutic hypothermia has been suggested to be induced in the field by direct venous or arterial infusion of chilled solutions, typically 0.9% saline (e.g., Lactated Ringer's Solution) which is available in most clinical settings. If this fluid is injected at a temperature near 0° C., the effective ‘cooling power’ applied to perfused tissue is directly proportional to body temperature and the rate of infusion. Increasing the mass flux of infusate will result in a greater rate of heat extraction from perfused tissue, but there is a limit to the rate and ultimate amount of fluids that may be safely infused. This requirement is made stricter by certain clinical conditions such as AMI (heart attack patients are not typically given large amounts of fluid in order to minimize stress to which the heart is subjected).
Therapeutic hypothermia has also been suggested to be induced by infusing a slush mixture. In particular, if the total volume of fluid which can be administered to AMI patients is limited, then raising the effective heat capacity of the infused fluid may allow effective application of therapeutic hypothermia. If the infused fluid were a slush, or a mixture of water ice and a saline solution chosen so that the bulk composition matches that of 0.9% saline, then in addition to the heat capacity of the liquid saline, the total heat absorbed during equilibration with body temperature would include the latent heat available in the infused ice. This technique increases the effective ‘cooling power’ available by infusion of chilled fluids. However, creating and maintaining a proper source and mixture of slush is complex.
In general, current techniques for administering such cooling tend to be non-standard and non-reproducible. Added to the above difficulties is that EMS care to cardiac arrest survivors tends to be very turbulent and hectic, and the availability of proper liquids, refrigeration capability, and delivery protocols is minimal.
Provided herein are methods, systems and apparatuses for use in delivering a cooled liquid to the vasculature of a subject in need thereof. As such, the methods, systems and apparatuses of this disclosure may be used, for example, to reduce the body temperature of a subject or to induce a therapeutic state of hypothermia in a subject. The methods, systems and apparatuses are of particular use in an emergency room or settings outside of a hospital. In some embodiments, the apparatuses are configured to fit and/or be used in an emergency vehicle (such as an ambulance, helicopter or other emergency medical services (EMS) vehicle). In some embodiments, the apparatuses or portions of the apparatuses are portable so that they can be used in the field and/or during transport of the subject. Accordingly, cool liquid can be provided to the subject as soon as possible and continuously until further treatment can be begin, if necessary.
In one embodiment, the invention provides an apparatus for use in delivering a cooled liquid from a liquid-containing package to the vasculature of a subject in need thereof, the apparatus comprising a portable unit adapted to contain at least one liquid-containing package and a fixed based unit, the portable unit being attachable and detachable to the fixed base unit. The fixed base unit includes a power supply system and a means for cooling a liquid-containing package when the package is contained by the portable unit. The apparatus is for use with a liquid-containing package that has a dispensing port for discharging the liquid therethrough and the portable unit or the package is adapted to receive a line for delivering the liquid to the subject.
In one embodiment, portable unit of the apparatus for use in delivering a cooled liquid from a liquid-containing package to the vasculature of a subject in need thereof includes a pressurizer adapted to be in pressure communication with the package to cause a set pressure to be incident in the package, wherein the liquid is caused to flow out of the package upon activation of a valve. In some embodiments, the portable unit includes a battery that powers the pressurizer. In some embodiments, the portable unit is adapted to contain two liquid-containing packages. In some embodiments, the liquid-containing package is a pressurizable package, such as a bag.
In some embodiments, the cooled liquid may be delivered to the subject without the use of a pressurizer. In such cases, the liquid may be delivered through a large bore needle and or in conjunction with a agent which facilitates liquid infusion in tissue.
Embodiments of the invention provide standard and reproducible methods and systems for inducing an artificial and therapeutic state of hypothermia in a patient, especially in emergency or pre-hospital settings. In certain embodiments, cold biocompatible liquid is infused into a patient at a defined temperature and pressure. The cold liquid may be infused at a fairly rapid rate to quickly induce hypothermia. In embodiments employing IV bags, unlike many such systems, operation is independent of the effects of gravity, and may be carried any with bags in any orientation or elevation, such as in a rescue helicopter.
In one embodiment, cold liquid is forced out of a refrigerated bag, the pressure on the bag arising from air pressure on the bag, an infusor cuff, or any other pressurization technique. The cold liquid may be cooled in advance of the infusion or via a cold plate which forms a portion of the system. The cold plate may be separated from the cold liquid and pressurization system prior to use. In another embodiment, the cold liquid is provided from a flowing source.
In one aspect, the invention is directed towards a method for inducing a therapeutic state of hypothermia. Steps include accessing a blood vessel of a patient, such that an intravenous line is fluidically coupled at a distal end to the interior of the patient's blood vessel; attaching a source of cooled liquid to a proximal end of the intravenous line, wherein the temperature of the cooled liquid is between about 0° C. and 10° C.; and pressurizing the source of cooled liquid such that cooled liquid is forced into the patient's blood vessel at a pressure of between about 100-500 mmHg+/−20%.
Implementations may include one or more of the following. The pressurizing may be such that between 0.5 and 2 liters of cooled liquid are delivered to the patient in a period of between about 15 minutes and 1 hour, and/or such that the patient's core temperature is depressed between about 0.5° C. and 2° C. over a period of time of between about 15 and 45 minutes. The source may be a flexible bag, and the pressurizing may include pressurizing the flexible bag. For example, the pressurizing may be performed by increasing the air pressure adjacent the bag or by mechanically squeezing the bag or by attaching a pump to the bag. The source of cooled liquid may be pre-cooled, such as by storing the source in an environment below room temperature, such as a cooler. The flexible bag may be an IV bag, and the pressurizing may be performed by an infusor bag. Air may be prevented from entering the patient's blood vessel by placing an air in-line eliminator between the source of cooled liquid and the patient's blood vessel.
Advantages of certain embodiments of the invention may include one or more of the following. The system and method may be highly standard and reproducible, leading to predictable delivery of cold liquids. The system and method are convenient to administer, and allow cooling for therapeutic hypothermia to be initiated rapidly following, for example, a heart malady or other ischemic situation.
Other details, features, and advantages will be apparent from the description that follows, including the drawings and figures.
In this description, where the same component or same type of component is used in different embodiments, it retains the same reference numeral. Also, terms like “fluidically coupled” and “pressure communication” refer to the situation where an increase of pressure at one point is communicated to another point due to the general incompressibility of liquids. In particular, these terms are used to describe a situation between two points in a flow or in a standing fluid. If pressure is applied at one point, the second point will eventually feel effects of the pressure if the two points are in pressure communication. Any number of valves or elements may be disposed between the two points, and the two points may still be in pressure communication if the above test is met. For example, for a standing fluid in a pipe, any number of pipe fittings may be disposed between two pipes and, so long as an open path is maintained, points in the respective pipes may still be in pressure communication.
The system 10 and 10′ (
The source of liquid may be either contained, such as from an IV bag, or flowing. In the first case, as shown in
In
The liquid may be pre-cooled, in which case no refrigeration is necessary (e.g., the liquid bag may be stored in a cooler or refrigerator prior to use). If the liquid is not pre-cooled, then the pressurizer may be used in conjunction with a refrigeration system 17 to cause the liquid to be cooled prior to or contemporaneous with infusion. For example, where a pressurizer forces liquid from a bag, one wall of the pressurizer may be formed of the cooling unit of a refrigerator. To enhance heat transfer, the non-pre-cooled liquid may flow through a serpentine path (such as in a cassette) that is in thermal communication with the refrigeration system. The cassette may contact the wall of a thermoelectric generator (TEG) or may be situated within a cold water bath (which may in turn be cooled by, e.g., a TEG). Alternatively, the entire pressurizer may be subject to the cooling action of a refrigeration system. Any refrigeration system may be employed which results in cooling and temperature reduction of the liquid as well as to maintain the temperature of the cooling liquid at a target value.
If the source of liquid is constantly flowing, such as from a tap source and as shown in
Whether the liquid is pumped or pressurized for pneumatic or mechanical pressure, the liquid may be forced into the patient via the intravenous line 14. To overcome the blood pressure, the liquid pressure may be greater than the blood pressure. Suitable pressures may be between about 100-500 mmHg+/−20%, more preferably 300 mmHg+/−10%, such as 300 mmHg (relative to ambient air pressure). Generally, the pressure has to be greater than that necessary to overcome the blood pressure in the blood vessel. In many cases, a maximum infusion pressure may be about 500 mmHg. The temperature of the infused liquid may be between about 0° C. and 10° C., more preferably 4° C. to 5° C.
Whatever the pressure, the pressurization should be such as to be able to infuse at a flow rate of, e.g., 100 ml/minute. In particular, if the clinical need is for, e.g., 30 mg/kg (30 milligrams of cold liquid per kilogram of patient body mass) over 15-30 minutes, then a 70 kg patient would require approximately 2 liters infused over the course of 30 minutes.
In any embodiment, as an additional safety feature, an air in-line eliminator 26 may be employed to remove any air bubbles from the fluid prior to its introduction into the patient. In this way, the chance of air entering the patient's bloodstream is reduced.
In any embodiment, suitable liquids that may be infused include saline, lactated Ringer's solution, or any other such biosafe liquid. In addition, the device or method can be used to administer a variety of liquids including, but not limited to, saline solutions, blood, blood volume expanding fluids, drugs, solutes, nutrients and other physiologic fluids.
As noted above, in one system, it is desired to infuse up to 2 liters of cold saline in 30 minutes. The exemplary system of
The system and method may employ a pressure feedback system to ensure that the infusion pressure does not reach beyond the desired pressure or to deleterious levels or that the infusion pressure maintains the desired liquid flow rate. In more detail, to ensure that the pressure is maintained at an appropriate level and does not reach unsafe levels, a pressure monitor may be employed that generates a signal that is fed back to a pressure controller. The pressure monitor may have a sensor that senses the pressure applied to a bag or other source of liquid, where that sensed pressure can be correlated with the pressure of the liquid infused. Alternatively, the pressure sensor may directly monitor the pressure of the liquid infused, such as via an in-line pressure sensor. Both such sensors may also be employed simultaneously in some systems. In any case, the pressure controller need not be a separate unit; rather, it may form a portion of a pump or a controller or the pressurization system. In particular, as shown in
Embodiments of the method of the invention are shown in
In
In
In another embodiment, as shown in
In particular, the system may be employed in an ambulance setting. To secure to an ambulance shelf, the fixed base unit may have a width of less than about 32″, a height (when combined with the portable unit) of less than about 16″, and a depth of less than about 20″. As such cabinets are generally several feet in front of the patient's head, any connections from the system to the patient may generally travel in front of the ambulance's side door to the patient. This travel is generally inconvenient, and thus the embodiment of
This system includes a fixed base unit 120 and a portable unit 110, the portable unit being attachable and detachable from the fixed base unit. The fixed base unit includes a cold plate 144 for cooling (or heating, if necessary) a liquid-containing bag such as an IV bag. The fixed base unit generally operates on wall-provided power, as may be available in an ambulance or a hospital, and an on/off switch 146 control delivery of this power to the cold plate 144. The system may also operate using the 12 volt battery system in an ambulance. To secure the fixed base unit against movement, the same may be locked down to the appropriate shelf in the ambulance. A temperature display 148 shows the temperature of the cold plate by virtue of a temperature sensor disposed in thermal communication with the same.
The portable unit 110 (which includes some disposable components and some reusable components, “disposable/reusable”) includes one and preferably two 1-liter IV bags 116 and 118 which may be placed and secured within pressurizable bags, such as infusor bags 122 and 124, respectively, which are in turn secured against a conductive plate 132 so that heat from the IV bags may be removed when the conductive plate 132 is placed atop the cold plate 144. In this way, the temperature of the IV bags is lowered as the liquid-containing bags are in thermal communication with the cold plate.
It is noted that while two 1-liter IV bags are discussed here, any number of such bags and infusor bags may be employed, according to the dictates of the user. Moreover, multiple IV bags may be placed within one infusor bag. Additionally, the liquid-containing bags need not be placed within the pressurizable bags; rather, any adjacent arrangement that allows the pressurizable bag to impart pressure on the liquid-containing bag may be employed. Finally, if sufficient thermal communication exists between the liquid-containing bags and the cold plate (often through the pressurizable bag), the conductive plate may be made smaller or eliminated.
When in preparation for use, the disposable/reusable portable unit 110 is placed (and optionally secured) to the fixed base unit 120, and the fixed base unit 120 is operated so as to cool the IV bags. When being readied for use with a patient, the disposable/reusable portable unit 110 is removed from the fixed base unit 120 and hung on an IV pole or other such attachment via IV tabs 126 and 128. For example, the disposable/reusable portable unit 110 may be hung from a hangar on the ceiling of the ambulance.
In some embodiments, the portable unit system generally includes the conductive plate, the infusor bag or bags, the IV bag or bags, as well as a pump, a pump battery, and monitoring circuitry for the pressurization. As noted above, the conductive plate may be omitted in arrangements where adequate thermal contact may be achieved directly between the cold plate and the combination of the IV bag and infusor bag. The pressurization may be via an air pump that is powered by a battery that forms part of the portable unit, and the battery may be recharged automatically upon contact with the fixed base unit. That is, the fixed base unit can recharge the pump battery when the portable unit is placed thereon. As discussed below, the pump may be controlled by appropriate monitoring circuitry.
The pump may also be operated by other techniques, include those involving gas cylinders or springs. Some other techniques, such as the use of pressurized gas, may eliminate the need for a pump: in this system, a controlled valve release air pressure that in turn pressurizes the liquid-containing bag.
The infusor bags 122 and 124 are pressurized to force fluid out of the IV bags at a set or determinable pressure. Some suitable pressure infusors that may be used are available from CasMed, Inc., Smiths Medical (and their Medex® unit), Cardinal Health (and their division Alaris® Medical Systems), Nellcor Puritan Bennett LLC (a division of Tyco Healthcare), and Mallinckrodt, Inc. (a division of Tyco Healthcare). Partial control of the flow of the fluid may be via a valve 142. The valve 142 is shown downstream of the y-connector 138, but similar valves may be disposed upstream of the y-connector 138 as well. A manometer may be included in the system, and the sensor for the same may be in one or more fluid lines from the IV bags 116 and 118, although in general the sensor may be located in any location that allows the same to measure the pressure of the liquid entering the patient. A pressure-setting knob 134 may be disposed on the system, as well as a pressure display 136. Various software or hardware or firmware may be employed to set a threshold pressure level, or maintain a specified pressure or flow rate, as well as to turn off the system if the threshold is exceeded. Alternatively, a physician may visually monitor display 136 for the in-line pressure, and control the same manually.
The method begins with installing one or more IV bags in a corresponding number of infusor bags (step 182). It is understood that various arrangements may be employed with specially-designed infusor bags such that more than one IV bag may be installed per infusor bag. The infusor bags may then be secured onto the conductive plate 132, or in some embodiments the infusor bags may be permanently secured thereon. If no conductive plate is employed, the pressurizable bags may be secured onto the housing containing the pump, pump battery, and monitoring circuitry. The monitoring circuit may also have a circuit arranged to monitor the temperature of the liquid in the liquid-containing bags.
The disposable/reusable portable unit 110 with the installed IV bags is then placed on the fixed base unit 120 (step 184). The fixed base unit 120 is operated so as to cool the bags (step 186). Power for the fixed base unit may be by way of a wall outlet in for example a hospital, an outlet in an emergency vehicle, for example an ambulance, which is powered by the vehicle battery, or an outlet in an emergency vehicle that is powered by an external power hook-up connected to the vehicle. Once the IV bag or bags are cooled to a suitable temperature, e.g., 4° C., the system is ready for use.
An EMS call may be received (step 188), and the system may travel to the patient (step 192). Of course, it is understood the system may be employed elsewhere, such as in a hospital or clinic setting. In any case, prior to and/or during any transit time to the patient, the fixed base unit 120 may operate to cool the bags within the disposable/reusable portable unit 110 so that their temperature is minimized by the time the system arrives at the patient (step 194) and infusion of cooled fluids is begun.
A first step in the method of treatment is to remove the disposable/reusable portable unit 110 from the fixed base unit 120 (step 196). The disposable/reusable portable unit 110 may then be installed on an IV pole or any other such device (step 198). As in embodiments above, an IV line may be installed in the patient (step 202). If a clamp or other valve mechanism has been employed on the administration or introduction set, the same is opened (step 204). The pressure is set on the disposable/reusable portable unit 110, and the infusor bags are appropriately and automatically pressurized (step 206) such that the pressure in the line achieves the set pressure. The pressure is monitored (step 208) and fed back to the system so that the set pressure is maintained to an appropriate degree of tolerance. The pressure may be set to the values described above.
As noted above, in any embodiment, the pressurization may occur via mechanical or pneumatic bag compression, via a separate pump, via an infusor cuff surrounding the source of liquid as described above, or via any other technique for forcing a liquid into a pressurized environment.
It should be noted that if packages, bags or other sources of liquid are only partially pre-cooled, the same may in addition undergo the refrigeration or other cooling steps noted above. The above steps are not intended to be mutually exclusive. Suitable refrigeration units may be available from, e.g., Engel USA, Sawafuji Electric Co. Ltd. (Japan). Suitable TEG systems are available from, e.g., TE Technology Inc. (Traverse City, Mich.).
Generally no anti-shivering drugs are required when the patients are comatose and no shivering response is activated. However, in the case where a shivering response is activated, anti-shivering drugs may be administered, such as meperidine, Demerol®, nefopam, buspirone, fentanyl, BuSpar, or any other anti-shivering drug.
The invention has been described with respect to a number of embodiments. One of ordinary skill in the art will recognize, however, that variations may be made within the scope and spirit of the invention. For example, while the invention has been generally described above in the context of an ambulance setting, the system and method may be used in an ER setting or in a hospital setting or in the field at the location of an injured individual (including e.g., nursing homes, military/battlefield sites). For example, in an ambulance setting, the system and method may be employed during a 20-30 minute ambulance ride to a treatment facility. Accordingly, the system described herein includes apparatus which are portable and powered by an AC and/or DC power source, including standard batteries or rechargeable batteries. Embodiments of the invention may be advantageously employed as part of a “crash cart” in an ambulance or hospital setting. Embodiments of the invention may be particularly useful in the treatment of cardiac arrest, stroke, traumatic injuries, unanticipated hyperthermia or hypothermia, and other such maladies. The system and method have been described primarily in the context of thermoelectric refrigerators, but conventional refrigerators and even non-refrigerated (but initially cooled, such as via ice packs) coolers may be employed. The system can be used for warming as well as cooling. In this case, the liquid should be delivered at a temperature greater than that of the body temperature, but usually less than about 42° C.
Accordingly, the invention is to be limited only by the claims appended hereto.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/964,630, filed Aug. 14, 2007, entitled “Pre-Hospital Cooling.” This application also claims the benefit of U.S. Provisional Patent Application Ser. No. 60/978,069, filed Oct. 5, 2007, entitled “Methods and Systems For Inducing Therapeutic Hypothermia In A Pre-Hospital, Field, or Ambulance Setting.” This application also claims the benefit of U.S. Provisional Patent Application Ser. No. 61/007,642, filed Dec. 14, 2007, entitled “Methods and Systems For Inducing Therapeutic Hypothermia In A Pre-Hospital, Field, or Ambulance Setting.” Each of the above-referenced prior applications is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
60964630 | Aug 2007 | US | |
60978069 | Oct 2007 | US | |
61007642 | Dec 2007 | US |